Observational study on gestational glucose tolerance in women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study recruits pregnant women in their late second trimester to assess their glucose tolerance status during pregnancy. Participants represent a range of glucose tolerance, from gestational diabetes to normal levels, and are followed over several years for cardiometabolic characterization. Regular assessments include evaluations of glucose tolerance, beta-cell function, and insulin sensitivity, aiming to understand the development of type 2 diabetes and cardiovascular disease post-pregnancy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnant women

Exclusion Criteria:

* Pre-existing diabetes before the index pregnancy

Where it's running

• Mount Sinai Hospital
  Toronto, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Ravi Retnakaran, MD — Mount Sinai Hospital
• Study coordinator: Ravi Retnakaran, MD
• Email: ravi.retnakaran@sinaihealth.ca
• Phone: 416-586-4800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Stiff Knee After Replacement: Test Hinged Revision with Low-Dose Radiation

  This trial tests whether adding low-dose radiation to a hinged revision knee replacement helps people with arthrofibrosis after knee replacement move their knee better.

  Recruiting Mount Sinai Hospital, Canada · Los Angeles, California and 3 other locations · NCT07767097

• Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

  This study tests whether using low molecular weight heparin with low-dose aspirin during pregnancy is as safe and effective as the standard warfarin-based approach for people with mechanical heart valves.

  Recruiting Mount Sinai Hospital, Canada · Toronto, Ontario · NCT07658989

• Recovery after stopping semaglutide: effects on weight, heart risk, and appetite

  This trial will test whether gradually lowering semaglutide instead of stopping it suddenly changes weight, heart risk markers, and appetite hormones in adults with obesity who lost at least 10% of their weight on semaglutide.

  Recruiting Phase 3 Mount Sinai Hospital, Canada · Toronto, Ontario · NCT07294950

• Time-restricted eating for adults with type 2 diabetes and overweight

  This project will test whether limiting daily eating to a shorter time window helps adults with type 2 diabetes and BMI ≥25 improve blood sugar control and preserve insulin-producing cells.

  Recruiting Mount Sinai Hospital, Canada · Toronto, Ontario · NCT07272460

• Inhaled methoxyflurane for pain during IUD insertion and endometrial biopsy.

  This trial will test whether inhaled methoxyflurane (Penthrox) reduces pain during IUD insertion or endometrial biopsy in adults aged 18–65.

  Recruiting Mount Sinai Hospital, Canada · Toronto, Ontario · NCT07046572

• T-piece versus ventilator breathing support at birth for extremely premature babies

  This will test whether using a ventilator to give precise nasal positive-pressure breaths at birth helps extremely premature infants (25–28 weeks) breathe better than the standard manual T‑piece resuscitator.

  Recruiting at 7 sites Mount Sinai Hospital, Canada · Los Angeles, California and 10 other locations · NCT06849596

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.